Clinical Trials Browser

Phase 2 × Carcinoma × Carboplatin × Clear all

Carcinoma, Endometrial Neoplasms

NCT06084845 2024-07-25

Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer

Phase 2 Withdrawn

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

NCT02412670 2023-07-10

Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer

Phase 2 Completed

36 enrolled 14 charts

Tumor-Agnostic

Carcinoma

NCT00176267 2023-06-01

Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer

Phase 2 Completed

26 enrolled

Tumor-Agnostic

Carcinoma, Carcinoma, Squamous Cell

NCT00176254 2023-05-16

Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer

Phase 2 Completed

40 enrolled 9 charts

Tumor-Agnostic

Carcinoma, Carcinoma, Squamous Cell

NCT00152477 2022-04-12

A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer

Phase 2 Completed

165 enrolled 16 charts

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT03128008 2021-05-28

ADAPT

Phase 2 Completed

10 enrolled 12 charts

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT02392507 2020-11-19

A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

Phase 2 Completed

54 enrolled 16 charts

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT02259582 2020-09-09

DENALI

Phase 2 Completed

82 enrolled 10 charts

Thoracic

Carcinoma, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Neoplasms

NCT01063075 2019-09-26

A Study in Advanced Solid Tumors

Phase 2 Completed

34 enrolled 15 charts

Head & NeckSarcoma

Carcinoma, Head and Neck Neoplasms, Sarcoma

NCT00226590 2017-03-23

Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC

Phase 2 Completed

39 enrolled 9 charts

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00737243 2016-08-17

Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site

Phase 2 Completed

289 enrolled 5 charts

Tumor-Agnostic

Carcinoma

NCT00998192 2016-03-31

A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung

Phase 2 Completed

32 enrolled

Tumor-Agnostic

Carcinoma, Neoplasm Metastasis

NCT00753038 2014-11-04

Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma

Phase 2 Completed

14 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma

NCT00034346 2007-12-24

ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

Phase 2 Completed

194 enrolled

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Neoplasms

Clinical Trials

RUBY-J

Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer

Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer

Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer

Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer

A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer

ADAPT

A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

DENALI

A Study in Advanced Solid Tumors

Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC

Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site

A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung

Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma

ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)